Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may ...

Nearly 10% of U.S. adults say they have been diagnosed with cancer, the highest figure since Gallup began tracking the ...

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

Pfizer's mRNA flu vaccine posts promising NEJM results. Dr. Todd Ellerin of South Shore Health discusses safety, side effects ...

Before casting a crucial vote for the health secretary, the top Senate Republican laid out several specific commitments he ...

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...